英文名稱 | Denosumab (anti-RANK ligand) | AMG-162 |
---|---|
中文名稱 | 地諾單抗 | 狄諾塞麥 | 地舒單抗 |
CAS號(hào) | 615258-40-7 |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3000.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥12500.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥20000.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥80000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥125000.00 | 登錄后可見(jiàn) |
英文名稱 | Denosumab (anti-RANK ligand) | AMG-162 |
---|---|
中文名稱 | 地諾單抗 | 狄諾塞麥 | 地舒單抗 |
CAS號(hào) | 615258-40-7 |
儲(chǔ)存條件 | Sealed and stored at ≤-30℃, away from light. Avoid freeze-thaw cycles |
Denosumab (anti-RANK ligand) (AMG-162, Prolia, Xgeva) is a fully human monoclonal antibody that selectively inhibits primate RANKL. Denosumab inhibits the ability of human RANKL (143–317) to stimulate the formation of osteoclasts derived from murine RAW 264.7 cells with an IC50 value of 1.64 nM.